Activity at phencyclidine and mu opioid sites mediates the hyperalgesic and antinociceptive properties of the N-terminus of substance P in a model of visceral pain

Neuroscience
V M Goettl, A A Larson

Abstract

Substance P, a putative neurotransmitter or neuromodulator of nociception or pain in the spinal cord, exhibits both antinociceptive and hyperalgesic properties. Investigators have shown that the N-terminal metabolite of substance P, substance P(1-7), produces naloxone-reversible antinociception when given supraspinally and systemically in mice and hyperalgesia when injected intrathecally in rats. The goal of our investigation was to identify the receptors mediating these actions of substance P(1-7) at the initial site of release of substance P, i.e. in the spinal cord. Thirty minutes after intrathecal injection, substance P(1-7) produced naloxone-reversible antinociception in a dose-dependent manner in the abdominal stretch assay. When administered with naloxone, substance P(1-7) produced hyperalgesia 5 and 10 min after injection, which was inhibited by dizocilpine (MK-801), a phencyclidine ligand and non-competitive antagonist of N-methyl-D-aspartate. Antinociception was inhibited by the mu-selective opioid antagonist beta-funaltrexamine, but not by the mu 1-selective opioid antagonist naloxonazine or the delta-selective antagonist naltrindole, indicating a mu 2-opioid receptor-mediated effect. These findings suggest that the ...Continue Reading

References

Aug 26, 1976·Nature·J M StewartE Zimmermann
Jun 25, 1990·Brain Research·M Herrera-MarschitzU Ungerstedt
Jan 1, 1991·Annals of the New York Academy of Sciences·M E HallJ M Stewart
Apr 1, 1988·Brain Research Bulletin·R A Cridland, J L Henry
Sep 22, 1989·European Journal of Pharmacology·D PaulG W Pasternak
Mar 1, 1985·Journal of Neurochemistry·T SakuradaL Terenius
Jan 27, 1988·European Journal of Pharmacology·P S PortogheseA E Takemori
Sep 23, 1986·European Journal of Pharmacology·G S LingG W Pasternak
Jan 1, 1988·Annual Review of Neuroscience·J E Maggio
Sep 1, 1982·Peptides·J M StewartW A Krivoy
Jan 1, 1983·Peptides·M E Hall, J M Stewart
Oct 17, 1980·European Journal of Pharmacology·J L Hylden, G L Wilcox

❮ Previous
Next ❯

Citations

Jun 23, 1994·European Journal of Pharmacology·V M GoettlZ Wiesenfeld-Hallin
Sep 1, 1995·General Pharmacology·C A Maggi
Mar 10, 2004·Pharmacology, Biochemistry, and Behavior·Louis P Vera-Portocarrero, Karin N Westlund
May 7, 1999·Brain Research Bulletin·S Fürst
Mar 20, 2012·Experimental Cell Research·Shanli TsuiLuo Lu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.